Financial

Straub Medical AG acquired by Becton, Dickinson and Company (BD)

(PresseBox) ( Wangs,04/21/20) Straub Medical AG, a privately held Swiss company, announces that it has approved a full acquisition by Becton, Dickinson and Company (BD). The acquisition was completed on April 20, 2020. Straub Medical AG is headquartered in Wangs, where it manufactures, develops and sells medical devices for the treatment of arterial […]

Stereotaxis Reports 2020 First Quarter Financial Results

ST. LOUIS, May 05, 2020 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the first quarter ended March 31, 2020. “Despite the challenges and disruptions inflicted by COVID-19, Stereotaxis continues to support the patients and physicians […]

Acesion Pharma Strengthens Clinical Team With Key Appointments

Appoints experienced Chief Medical Officer and Director Clinical Operations COPENHAGEN, Denmark, May 5, 2020 /PRNewswire/ — Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhythmia, today announced that it has recruited Anders Gaarsdal Holst as its Chief Medical Officer (CMO) to succeed Nils Edvardsson, who […]

Venus Medtech and Opus Medical Therapies, LLC Announce Partnership for Transcatheter Mitral Valve Replacement (TMVR) and Transcatheter Tricuspid Valve Replacement (TTVR) in Greater China Market

HANGZHOU, China and ATLANTA, May 2, 2020 /PRNewswire/ — Venus Medtech (Hangzhou) Inc. (“Venus Medtech” or the “Company”, together with its subsidiaries, the “Group”, stock code: 2500), the leading Chinese transcatheter heart valve company and Opus Medical Therapies, LLC, a medical device company focused on developing transcatheter mitral and tricuspid valve replacement products for patients undergoing […]

Sequana Medical Announces the Appointment of Dr. Oliver Gödje as Chief Medical Officer

GHENT, Belgium, May 04, 2020 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces the appointment of Oliver Gödje, MD, PhD, as Chief Medical Officer, with immediate effect. Dr Gödje replaces Gijs Klarenbeek, MD, […]